No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Delhi High Court Refuses Interim Injunction Against Zydus’ Pertuzumab Biosimilar
On 9 July 2024, Roche received a temporary injunction order against Zydus from a previous bench of the Delhi High Court, restraining Zydus from marketing or selling their product Sigrima™, biosimilar to Roche’s Perjeta® (pertuzumab), till the next date of hearing. The...